Hans T. Schambye
Chief Executive Officer · Damora Therapeutics, Inc.
- 2024
- Jan 6, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Hans T. Schambye files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Jarrett - $253K in DMRA purchases and sales in the last 12 months
- Garrett Winslow - $13K in DMRA purchases and sales in the last 12 months
- Lori Firmani - $3K in DMRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Hans T. Schambye?
Hans T. Schambye is a corporate insider, tracked as Chief Executive Officer of Damora Therapeutics, Inc. (DMRA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Hans T. Schambye last file a Form 4?
The most recent primary Form 4 on record is dated 6 January 2026, one of 3 filings going back to 2024.
Has Hans T. Schambye been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($17K) across all tracked filings.
